Botanix Pharmaceuticals Limited (ASX:BOT)
Australia · Delayed Price · Currency is AUD 0.0220
0.00 (0.00%)
Jun 19, 2026, 4:10 PM AEST
Botanix Pharmaceuticals Market Cap
Botanix Pharmaceuticals has a market cap or net worth of 60.15 million as of June 18, 2026. Its market cap has decreased by -90.70% in one year.
Market Cap
60.15M
Enterprise Value
29.62M
Revenue
21.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since July 15, 2016, Botanix Pharmaceuticals's market cap has increased from 12.26M to 60.15M, an increase of 390.48%. That is a compound annual growth rate of 17.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 60.15M | -77.36% |
| Dec 31, 2025 | 265.72M | -66.39% |
| Dec 31, 2024 | 790.67M | 168.97% |
| Dec 29, 2023 | 293.96M | 367.07% |
| Dec 30, 2022 | 62.94M | 15.49% |
| Dec 31, 2021 | 54.50M | -55.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 15, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Paradigm Biopharmaceuticals | 89.33M |
| Arovella Therapeutics | 85.82M |
| Immutep | 78.11M |
| Prescient Therapeutics | 71.50M |
| Radiopharm Theranostics | 70.88M |
| Amplia Therapeutics | 59.03M |
| Avecho Biotechnology | 57.46M |
| Entropy Neurodynamics | 48.95M |